Updates News Archive EsoCap appoints Jacques Gonella to its board of directors Read More June 9, 2020 EsoCap selected as a top drug discovery and development provider by Pharma Tech Outlook Read More May 13, 2020 EsoCap announces issue of a patent in Russia for its smart application technology for the upper gastrointestinal tract Read More March 12, 2020 EsoCap selected as finalist to present at the RESI Europe 2020 Innovation Challenge on March 23, 2020 Read More March 3, 2020 EsoCap announces that its application device is CE certified after meeting the requirements of the European medical device directive Read More February 28, 2020 EsoCap announces presentation of new data at the American Association of Pharmaceutical Scientists’ Congress Read More November 6, 2019 EsoCap receives orphan drug designation from the US food & drug administration for ESO-101 Read More July 23, 2019 EsoCap holds a multidisciplinary scientific advisory board meeting with thirteen international experts Read More June 27, 2019 EsoCap announces authorisation of capital increase by extraordinary general assembly and successful closing of its private placement offering Read More April 30, 2019 EsoCap one of just a handful of companies selected to present at the Bio-Europe conference start up spotlight on March 26, 2019 Read More March 8, 2019 « Previous Page1 Page2 Page3 Next »
EsoCap selected as a top drug discovery and development provider by Pharma Tech Outlook Read More May 13, 2020
EsoCap announces issue of a patent in Russia for its smart application technology for the upper gastrointestinal tract Read More March 12, 2020
EsoCap selected as finalist to present at the RESI Europe 2020 Innovation Challenge on March 23, 2020 Read More March 3, 2020
EsoCap announces that its application device is CE certified after meeting the requirements of the European medical device directive Read More February 28, 2020
EsoCap announces presentation of new data at the American Association of Pharmaceutical Scientists’ Congress Read More November 6, 2019
EsoCap receives orphan drug designation from the US food & drug administration for ESO-101 Read More July 23, 2019
EsoCap holds a multidisciplinary scientific advisory board meeting with thirteen international experts Read More June 27, 2019
EsoCap announces authorisation of capital increase by extraordinary general assembly and successful closing of its private placement offering Read More April 30, 2019
EsoCap one of just a handful of companies selected to present at the Bio-Europe conference start up spotlight on March 26, 2019 Read More March 8, 2019
